Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody

Franz O. Smith, Stephanie L. Goff, Jacob A. Klapper, Catherine Levy, Tamika Allen, Sharon A. Mavroukakis, Steven A. Rosenberg

Research output: Contribution to journal › Letter › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody'. Together they form a unique fingerprint.